Insider · CIK 0001801842
Ashley Hall
Files at GPCR (Structure Therapeutics Inc.). First filing -, latest -.
In brief
Ashley Hall files SEC Form 4 as officer at GPCR (Structure Therapeutics Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Ashley Hall has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 19, 2026 | GPCR Structure Therapeutics Inc. | AGrant or award Ordinary Shares | +47,706 | $0.00 | $0 | 155,187 | Mar 23, 2026 |
| Mar 19, 2026 | GPCR Structure Therapeutics Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +59,073 | $0.00 | $0 | 59,073 | Mar 23, 2026 |
| Mar 3, 2026 | GPCR Structure Therapeutics Inc. | FTax withholding Ordinary Shares | -4,836 | $20.99 | $102k | 107,481 | Mar 5, 2026 |
| May 20, 2025 | GPCR Structure Therapeutics Inc. | AGrant or award American Depositary Sharesderivative | +225 | $0.00 | $0 | 225 | Mar 5, 2026 |
| Nov 20, 2025 | GPCR Structure Therapeutics Inc. | AGrant or award American Depositary Sharesderivative | +237 | $0.00 | $0 | 462 | Mar 5, 2026 |
| Sep 18, 2025 | GPCR Structure Therapeutics Inc. | FTax withholding Ordinary Shares | -6,021 | $7.74 | $47k | 112,317 | Sep 22, 2025 |
| Mar 15, 2025 | GPCR Structure Therapeutics Inc. | AGrant or award Ordinary Shares | +51,048 | $0.00 | $0 | 118,338 | Mar 18, 2025 |
| Mar 15, 2025 | GPCR Structure Therapeutics Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +124,032 | $0.00 | $0 | 124,032 | Mar 18, 2025 |
Questions about Ashley Hall
Answered from the filings on this page, as of the latest one.
Is Ashley Hall buying or selling?
Ashley Hall has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Ashley Hall's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ashley Hall has 0.
Where does Ashley Hall file Form 4?
Ashley Hall has filed Form 4 at GPCR (Structure Therapeutics Inc.) as Chief Development Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.